Steroids and enhanced antibiotics for sepsis in people with HIV
Part of Infections clinical trials.
This study tests whether a combination of steroids (a type of medicine that reduces inflammation) and stronger antibiotics can help people with HIV who have a serious infection (sepsis) that is not getting better with standard treatment. If you qualify, you may receive this extra treatment to see if it helps you recover.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and living with HIV.
- You are currently hospitalized with a suspected infection and have signs like confusion, fast breathing, or low blood pressure.
- You do not have active tuberculosis (TB) and are not on TB treatment.
- You are not pregnant or breastfeeding.
- You have no known liver disease or severe alcohol use.
- You have not taken steroids or other experimental drugs recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a quick set of tests to figure out whether a person with severe infection (sepsis) will respond to corticosteroids like hydrocortisone. The goal is to guide treatment sooner and avoid ineffective care.
This study tests different treatment plans for people with tuberculosis (TB) that can be cured with standard medicines. It aims to find the best treatment for each person based on their risk score, which may lead to shorter or more effective treatment.
This study tests whether a corticosteroid (a type of anti-inflammatory medicine) can help people with severe breathing problems or serious infections who have a specific 'hyperinflammatory' pattern. If you are in the ICU on a ventilator, this trial may be an option for you.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
This trial tests whether adding omega-3 (fish oil) to standard TB treatment helps clear the infection faster and reduces inflammation. You may be eligible if you have confirmed lung TB and meet a few health criteria.
This study tests whether adding the cholesterol drug atorvastatin to standard TB treatment helps people recover faster. It is for people with newly diagnosed, drug-sensitive tuberculosis who have not yet started treatment.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.